Dr. Asem Qadeer, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,293 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inari Medical, Inc. | $279.97 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $269.87 | 3 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $125.00 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $116.45 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $90.01 | 4 | $0 (2024) |
| Chiesi USA, Inc. | $47.19 | 3 | $0 (2022) |
| Baxter Healthcare | $45.29 | 1 | $0 (2023) |
| Cumberland Pharmaceuticals, Inc. | $32.09 | 2 | $0 (2021) |
| Melinta Therapeutics, LLC | $29.93 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.48 | 3 | Merck Sharp & Dohme LLC ($47.21) |
| 2023 | $114.98 | 4 | Baxter Healthcare ($45.29) |
| 2022 | $54.31 | 3 | Chiesi USA, Inc. ($29.64) |
| 2021 | $785.98 | 12 | Inari Medical, Inc. ($279.97) |
| 2020 | $269.87 | 3 | GlaxoSmithKline, LLC. ($269.87) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $20.27 | General |
| Category: HFCWO | ||||||
| 02/22/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/27/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/17/2023 | Baxter Healthcare | Hillrom - Vest System Model 205 Acute Care (Device) | Food and Beverage | In-kind items and services | $45.29 | General |
| Category: Airway Clearance Device | ||||||
| 03/02/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Immunology | ||||||
| 08/25/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/24/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/28/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Respiratory | ||||||
| 08/16/2021 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Vabomere | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: ANTIBIOTICS | ||||||
| 07/16/2021 | Cumberland Pharmaceuticals, Inc. | VAPRISOL DEXTROSE IN PLASTIC CONTAINER (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: NEPHROLOGY | ||||||
| 07/07/2021 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/02/2021 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 05/05/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 04/26/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/31/2021 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $155.01 | General |
| Category: VTE | ||||||
| 03/24/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $116.45 | General |
| 03/16/2021 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/24/2021 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: VTE | ||||||
| 02/09/2021 | Cumberland Pharmaceuticals, Inc. | VAPRISOL DEXTROSE IN PLASTIC CONTAINER (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: NEPHROLOGY | ||||||
| 10/05/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $119.93 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 680 | 968 | $405,110 | $118,671 |
| 2022 | 16 | 687 | 1,043 | $455,270 | $147,452 |
| 2021 | 9 | 269 | 388 | $119,098 | $42,204 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 173 | 339 | $197,250 | $59,566 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 76 | 113 | $55,140 | $16,419 | 29.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 102 | $29,160 | $10,083 | 34.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 44 | 100 | $30,000 | $9,022 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $20,460 | $6,213 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $18,600 | $5,132 | 27.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 41 | $16,605 | $4,462 | 26.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 41 | 41 | $8,405 | $1,995 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,340 | $1,692 | 31.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 42 | 42 | $6,720 | $1,543 | 23.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 49 | 49 | $9,100 | $1,078 | 11.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 19 | 19 | $5,225 | $634.60 | 12.1% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 11 | 14 | $1,075 | $406.00 | 37.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 12 | 12 | $1,440 | $339.48 | 23.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 13 | 13 | $590.00 | $86.45 | 14.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 204 | 430 | $249,400 | $88,592 | 35.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 74 | 162 | $46,215 | $16,880 | 36.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 86 | 116 | $31,550 | $10,919 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 46 | $26,550 | $7,672 | 28.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 33 | $16,995 | $6,036 | 35.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 41 | 41 | $11,685 | $3,758 | 32.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $9,435 | $2,690 | 28.5% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 18 | 19 | $8,650 | $2,687 | 31.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 33 | 33 | $6,555 | $1,907 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $5,400 | $1,645 | 30.5% |
About Dr. Asem Qadeer, MD
Dr. Asem Qadeer, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1770961898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Asem Qadeer, MD has received a total of $1,293 in payments from pharmaceutical and medical device companies, with $67.48 received in 2024. These payments were reported across 25 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,293).
As a Medicare-enrolled provider, Qadeer has provided services to 1,636 Medicare beneficiaries, totaling 2,399 services with total Medicare billing of $308,327. Data is available for 3 years (2021–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Pulmonary Disease
- Location Stony Brook, NY
- Active Since 05/08/2015
- Last Updated 05/24/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1770961898
Products in Payments
- FLOWTRIEVER CATHETER, S (Device) $279.97
- NUCALA (Biological) $244.89
- ACTHAR (Biological) $125.00
- CLEVIPREX (Drug) $47.19
- Hillrom - Vest System Model 205 Acute Care (Device) $45.29
- DIFICID (Drug) $44.06
- VAPRISOL DEXTROSE IN PLASTIC CONTAINER (Drug) $32.09
- Kimyrsa (Drug) $29.93
- DUPIXENT (Biological) $26.89
- TRELEGY ELLIPTA (Drug) $24.98
- Fetroja (Drug) $24.67
- YUPELRI (Drug) $23.69
- ZERBAXA (Drug) $23.68
- VERQUVO (Drug) $22.27
- Arikayce (Drug) $21.53
- SMARTVEST (Device) $20.27
- CRESEMBA (Drug) $14.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Stony Brook
Noreen Bukhari-Parlakturk, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $26,258
Aadit Shah, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $18,802
Kristine Jang, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $18,437
Mr. Stuart Drew
Student in an Organized Health Care Education/Training Program — Payments: $10,662
Dr. Brian Mccormack, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $9,541
Sonya Marcus, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,616